Generated by All in One SEO v5.0.0.1, this is an llms.txt file, used by LLMs to index the site. # Association of European Cancer Leagues - ECL The Association of European Cancer Leagues (ECL) works in cancer prevention and cancer control, including tobacco control, access to medicines, patient support, MEPs Against Cancer, and disseminates the European Code Against Cancer ## Sitemaps - [XML Sitemap](https://www.cancer.eu/sitemap.xml): Contains all public & indexable URLs for this website. ## Posts - [Clean air is cancer prevention: ECL joins call to phase out fossil fuels](https://www.cancer.eu/clean-air-is-cancer-prevention-ecl-joins-call-to-phase-out-fossil-fuels/) - [ECL recommendations for the European Biotech Act](https://www.cancer.eu/ecl-recommendations-for-the-european-biotech-act/) - [New EFPN study uncovers hidden medicine price deals are growing fast across Europe](https://www.cancer.eu/new-efpn-study-uncovers-hidden-medicine-price-deals-are-growing-fast-across-europe/) - [Tobacco Products Directive & Tobacco Advertising Directive: ECL response to call for evidence](https://www.cancer.eu/tobacco-products-directive-tobacco-advertising-directive-ecl-response-to-call-for-evidence/) - [ECL and 14 other organisations call for the European Biotech Act to better respond to public health needs](https://www.cancer.eu/ecl-and-14-other-organisations-call-for-the-european-biotech-act-to-better-respond-to-public-health-needs/) - [Event: Protecting youth from commercial determinants of health](https://www.cancer.eu/protecting-youth-from-commercial-determinants-of-health/) - [ECL marks 30 years of ECToH with urgent call for EU tobacco directives](https://www.cancer.eu/ecl-marks-30-years-of-ectoh-with-urgent-call-for-eu-tobacco-directives/) - [European cancer leagues call for revision of outdated Transparency Directive](https://www.cancer.eu/european-cancer-leagues-call-for-revision-of-outdated-transparency-directive/) - [Critical Medicines Act opens doors to more equitable access to cancer medicines](https://www.cancer.eu/critical-medicines-act-opens-doors-to-more-equitable-access-to-cancer-medicines/) - [ECL and 15 organisations call on EU to invest €1 billion in exposome research ](https://www.cancer.eu/ecl-and-15-organisations-call-on-eu-to-invest-e1-billion-in-exposome-research/) - [Materials for the European Week Against Cancer 2026](https://www.cancer.eu/materials-for-the-european-week-against-cancer-2026/) - [European Week Against Cancer 2026](https://www.cancer.eu/european-week-against-cancer-2026/) - [European Week Against Cancer 2025](https://www.cancer.eu/european-week-against-cancer-2025/) - [International Workers’ Day 2026: Supporting cancer patients return to the workplace ](https://www.cancer.eu/international-workers-day-2026-supporting-cancer-patients-return-to-the-workplace/) - [European cancer leagues call on the European Parliament to act against carcinogens in cosmetics](https://www.cancer.eu/european-cancer-leagues-call-on-the-european-parliament-to-act-against-carcinogens-in-cosmetics/) - [New European Commission report confirms urgent need to reform EU tobacco rules](https://www.cancer.eu/new-european-commission-report-confirms-urgent-need-to-reform-eu-tobacco-rules/) - [Policy paper: Regulating novel and emerging nicotine and tobacco products](https://www.cancer.eu/regulating-novel-and-emerging-nicotine-and-tobacco-products-european-cancer-leagues-recommendations/) - [A call on countries to ensure access to affordable medicines](https://www.cancer.eu/a-call-on-countries-to-ensure-access-to-affordable-medicines/) - [Wolfgang Fecke appointed as ECL's new Executive Director](https://www.cancer.eu/wolfgang-fecke-appointed-as-ecls-new-executive-director/) - [Tobacco industry infiltrates advisory process on EU Tobacco Tax Directive](https://www.cancer.eu/tobacco-industry-infiltrates-advisory-process-on-eu-tobacco-tax-directive/) - [Letter: The next EU budget can be a driver for clean air](https://www.cancer.eu/letter-the-next-eu-budget-can-be-a-driver-for-clean-air/) - [Ensuring equitable access: Cancer leagues call for an ambitious Critical Medicines Act](https://www.cancer.eu/cancer-leagues-call-for-an-ambitious-critical-medicines-act/) - [Some hospitals pay more than double for the same cancer drugs](https://www.cancer.eu/some-hospitals-pay-more-than-double-for-the-same-cancer-drugs/) - [How to manage cancer at work: Tips for employers supporting employees with cancer](https://www.cancer.eu/how-to-manage-cancer-at-work-tips-for-employers-supporting-employees-with-cancer/) - [International Workers' Day 2025](https://www.cancer.eu/international-workers-day-2025/) - [Tobacco taxes remain the most cost-effective measure to reduce tobacco consumption ](https://www.cancer.eu/tobacco-taxes-remain-the-most-cost-effective-measure-to-reduce-tobacco-consumption/) - [EU Healthy Air Coalition launches new infographic to mark Clean Air Day](https://www.cancer.eu/eu-healthy-air-coalition-launches-new-infographic-to-mark-clean-air-day/) - [ECL responds to EU consultation on the Tobacco Tax Directive revision ](https://www.cancer.eu/ecl-responds-to-eu-consultation-on-the-tobacco-tax-directive-revision/) - [European Cancer Leagues call on EU Commissioner Hoekstra to prevent cancer by strengthening the EU Tobacco Taxation Directive](https://www.cancer.eu/european-cancer-leagues-call-on-eu-commissioner-hoekstra-to-prevent-cancer-by-strengthening-the-eu-tobacco-taxation-directive/) - [Letter: European collaboration on equal access to cancer medicines and the role of EU competition policy](https://www.cancer.eu/letter-european-collaboration-on-equal-access-to-cancer-medicines-and-the-role-of-eu-competition-policy/) - [Letter: Supporting the Italian draft resolution on improving the transparency of markets for medicines and vaccines](https://www.cancer.eu/letter-supporting-the-italian-draft-resolution-on-improving-the-transparency-of-markets-for-medicines-and-vaccines/) - [Letter: Request to start an investigation into the factors leading to medicines shortages](https://www.cancer.eu/letter-request-to-start-an-investigation-into-the-factors-leading-to-medicines-shortages/) - [Letter: Prevention of medicine shortages through the constitution of safety stocks](https://www.cancer.eu/letter-prevention-of-medicine-shortages-through-the-constitution-of-safety-stocks/) - [Letter: Publish the proposed revision of the EU pharmaceutical legislation NOW](https://www.cancer.eu/letter-publish-the-proposed-revision-of-the-eu-pharmaceutical-legislation-now/) - [Letter: Cancer patients need a patient-centred and fit for purpose pharmaceutical system](https://www.cancer.eu/letter-cancer-patients-need-a-patient-centred-and-fit-for-purpose-pharmaceutical-system/) - [Letter to President von der Leyen: Delayed publication of the EU pharmaceutical legislation revision](https://www.cancer.eu/letter-to-president-von-der-leyen-delayed-publication-of-the-eu-pharmaceutical-legislation-revision/) - [ECL welcomes the Council's agreement on a mandate to start negotiations on health technology assessments (HTA)](https://www.cancer.eu/ecl-welcomes-the-councils-agreement-on-a-mandate-to-start-negotiations-on-health-technology-assessments-hta/) - [ECL welcomes the Council's mandate to start negotiations on the HTA file](https://www.cancer.eu/ecl-welcomes-the-councils-mandate-to-start-negotiations-on-the-hta-file/) - [Infographic: Access to medicines for all cancer patients](https://www.cancer.eu/infographic-access-to-medicines-for-all-cancer-patients/) - [Position paper: European cooperation on Health Technology Assessment (HTA)](https://www.cancer.eu/position-paper-european-cooperation-on-health-technology-assessment-hta/) - [White Paper: Tackling challenges in access to medicines for all cancer patients](https://www.cancer.eu/white-paper-tackling-challenges-in-access-to-medicines-for-all-cancer-patients/) - [How the European Medicines Agency engages with medicine producers before they apply for authorisations](https://www.cancer.eu/how-the-european-medicines-agency-engages-with-medicine-producers-before-they-apply-for-authorisations/) - [Public consultation: European Medicines Agency Regulatory Science to 2025 ](https://www.cancer.eu/public-consultation-european-medicines-agency-regulatory-science-to-2025/) - [Report: What's next on transparency?](https://www.cancer.eu/report-whats-next-on-transparency/) - [Public consultation: Europe’s Beating Cancer Plan Roadmap ](https://www.cancer.eu/public-consultation-europes-beating-cancer-plan-roadmap/) - [Public consultation: The Pharmaceutical Strategy Roadmap ](https://www.cancer.eu/public-consultation-the-pharmaceutical-strategy-roadmap/) - [Joint recommendations: Towards fair prices of medicines in Europe ](https://www.cancer.eu/joint-recommendations-towards-fair-prices-of-medicines-in-europe/) - [Public consultation: Pilot project ‘Market Launch of Intentions of Centrally Authorised Products’](https://www.cancer.eu/public-consultation-pilot-project-market-launch-of-intentions-of-centrally-authorised-products/) - [Public consultation: Intellectual Property Action Plan ](https://www.cancer.eu/public-consultation-intellectual-property-action-plan/) - [Position paper: Europe’s Pharmaceutical Strategy ](https://www.cancer.eu/position-paper-europes-pharmaceutical-strategy/) - [Report: What is fair pricing?](https://www.cancer.eu/report-what-is-fair-pricing/) - [Support of Aspen Pharma commitments on excessive pricing  ](https://www.cancer.eu/support-of-aspen-pharma-commitments-on-excessive-pricing/) - [ECL’s contribution to the 2021 WHO Fair Pricing Forum ](https://www.cancer.eu/ecls-contribution-to-the-2021-who-fair-pricing-forum/) - [Civil society recommendations for improving the Orphan and Paediatric Regulations ](https://www.cancer.eu/civil-society-recommendations-for-improving-the-orphan-and-paediatric-regulations/) - [Joint recommendations: The Health Technology Assessment ](https://www.cancer.eu/joint-recommendations-the-health-technology-assessment/) - [Infographic: 4 ways towards successful European cooperation on HTA ](https://www.cancer.eu/infographic-4-ways-towards-successful-european-cooperation-on-hta/) - [Report: Cross-border collaboration initiatives in the healthcare space ](https://www.cancer.eu/report-cross-border-collaboration-initiatives-in-the-healthcare-space/) - [Infographic: ECL recommendations for the revision of the Pharmaceutical Legislation ](https://www.cancer.eu/infographic-ecl-recommendations-for-the-revision-of-the-pharmaceutical-legislation/) - [Motion for a European Parliament resolution on a pharmaceutical strategy for Europe ](https://www.cancer.eu/motion-for-a-european-parliament-resolution-on-a-pharmaceutical-strategy-for-europe/) - [Position paper: The revision of the Orphan Medicinal Products Regulation](https://www.cancer.eu/position-paper-the-revision-of-the-orphan-medicinal-products-regulation/) - [Feedback on the European Commission’s proposal on a European Health Data Space  ](https://www.cancer.eu/feedback-on-the-european-commissions-proposal-on-a-european-health-data-space/) - [Cancer community urges EU economic and finance ministers to back ambitious tobacco tax policy ](https://www.cancer.eu/european-cancer-community-urges-eu-economic-and-finance-ministers-to-back-ambitious-tobacco-tax-policy/) - [European health organisations call for ambitious tobacco tax policy ](https://www.cancer.eu/european-health-organisations-call-for-ambitious-tobacco-tax-policy/) - [New CBIG-Screen toolkit and policy recommendations target inequalities in cervical cancer screening](https://www.cancer.eu/new-cbig-screen-toolkit-and-policy-recommendations-target-inequalities-in-cervical-cancer-screening/) - [Report: The potential for academic development of medicines in Europe ](https://www.cancer.eu/report-the-potential-for-academic-development-of-medicines-in-europe/) - [ECL and Anticancer Fund recommendations for the revision of the EU general pharmaceutical legislation ](https://www.cancer.eu/ecl-and-anticancer-fund-recommendations-for-the-revision-of-the-eu-general-pharmaceutical-legislation/) - [Infographic: Access to medicines for all patients with rare diseases  ](https://www.cancer.eu/infographic-access-to-medicines-for-all-patients-with-rare-diseases/) - [ECL and EFPN recommendations for the revision of the EU legislation of medicines for rare diseases  ](https://www.cancer.eu/ecl-and-efpn-recommendations-for-the-revision-of-the-eu-legislation-of-medicines-for-rare-diseases/) - [Stakeholders call for the protection of the hospital exemption ](https://www.cancer.eu/stakeholders-call-for-the-protection-of-the-hospital-exemption/) - [Recommendations for the draft EU Parliament’s ENVI Committee reports for the pharma package ](https://www.cancer.eu/recommendations-for-the-draft-eu-parliaments-envi-committee-reports-for-the-pharma-package/) - [EU elections: Take control to ensure access to medicines in the EU ](https://www.cancer.eu/eu-elections-take-control-to-ensure-access-to-medicines-in-the-eu/) - [ECL and EFPN call for 6-year data protection period and incentives for accessible medicines](https://www.cancer.eu/ecl-and-efpn-call-for-6-year-data-protection-period-and-incentives-for-accessible-medicines/) - [Better access to medicines through reduced regulatory data protection and modulated incentives](https://www.cancer.eu/better-access-to-medicines-through-reduced-regulatory-data-protection-and-modulated-incentives-2/) - [ECL and EFPN recommendations for the EU pharma package trilogue](https://www.cancer.eu/recommendations-for-the-eu-pharma-package-trilogue/) - [Better access to medicines through reduced regulatory data protection and modulated incentives](https://www.cancer.eu/better-access-to-medicines-through-reduced-regulatory-data-protection-and-modulated-incentives/) - [Joint statement: Strengthening the hospital exemption in the EU Pharma Directive](https://www.cancer.eu/joint-statement-strengthening-the-hospital-exemption-in-the-eu-pharma-directive/) - [Recommendations for a new Directive on medicinal products for human use  ](https://www.cancer.eu/recommendations-for-a-new-directive-on-medicinal-products-for-human-use/) - [TRANSCEND-XR launches World Café discussions](https://www.cancer.eu/transcend-xr-launches-world-cafe-discussions/) - [Webinar: What do we know about Forever Chemicals?](https://www.cancer.eu/webinar-pfas-and-cancer-what-do-we-know-about-forever-chemicals/) - [Webinar: What does the European Health Data Space mean for cancer control?](https://www.cancer.eu/webinar-what-does-the-european-health-data-space-mean-for-cancer-control/) - [Health and consumer groups urge EU governments to prioritise health in EU pharma reform](https://www.cancer.eu/eu-pharma-reform-health-and-consumer-groups-urge-eu-governments-to-put-health-over-profit/) - [Letter: REACH revision to prevent disease and reduce health costs](https://www.cancer.eu/letter-reach-revision-to-prevent-disease-and-reduce-health-costs/) - [ECL’s vision for the revision of the Audiovisual Media Service Directive](https://www.cancer.eu/ecls-vision-for-the-revision-of-the-audiovisual-media-service-directive/) - [EU Parliament backs strong measures to secure affordable cancer medicines ](https://www.cancer.eu/the-eu-parliament-backs-strong-measures-to-secure-affordable-cancer-medicines/) - [New European Code Against Cancer gives governments tools to strengthen prevention](https://www.cancer.eu/new-european-code-against-cancer-gives-governments-tools-to-strengthen-prevention/) - [Letter: No contradiction between clean air efforts and measures on the housing crisis](https://www.cancer.eu/letter-no-contradiction-between-clean-air-efforts-and-measures-on-the-housing-crisis/) - [Webinar: Breaking down the barriers around cancer and work](https://www.cancer.eu/webinar-breaking-down-the-barriers-around-cancer-and-work/) - [Webinar: Supporting cancer patients and survivors in the workplace](https://www.cancer.eu/webinar-supporting-cancer-patients-and-survivors-in-the-workplace/) - [Webinar: How can Europe improve access to diagnoses, treatment and care for paediatric cancer patients?](https://www.cancer.eu/webinar-how-can-europe-improve-access-to-diagnoses-treatment-and-caer-for-paediatric-cancer-patients/) - [Webinar: The potential for academic development of medicines in Europe ](https://www.cancer.eu/webinar-the-potential-for-academic-development-of-medicines-in-europe/) - [Webinar: How can the EU pharma reform improve cancer patients’ access to treatments?](https://www.cancer.eu/webinar-how-can-the-eu-pharma-reform-improve-cancer-patients-access-to-treatments/) - [Infographic: ECL sun safety recommendations ](https://www.cancer.eu/infographic-ecl-sun-safety-recommendations/) - [The case for a PFAS-free future: the link between forever chemicals and cancer](https://www.cancer.eu/the-case-for-a-pfas-free-future-the-link-between-forever-chemicals-and-cancer/) - [The EU Safe Hearts Plan targets shared risk factors behind cardiovascular disease and cancer](https://www.cancer.eu/eu-safe-hearts-plan-targets-shared-risk-factors-behind-cardiovascular-disease-and-cancer/) - [Event: Improving outcomes, driving efficiency in cancer care](https://www.cancer.eu/event-improving-outcomes-driving-efficiency-in-cancer-care/) - [Event: How can we improve the quality of care provided to cancer patients in Europe?](https://www.cancer.eu/event-how-can-we-improve-the-quality-of-care-provided-to-cancer-patients-in-europe/) - [Roundtable: Safe work under the sun](https://www.cancer.eu/roundtable-safe-work-under-the-sun/) - [MEPs Against Cancer highlight challenges in early diagnosis and cancer of unknown primary](https://www.cancer.eu/meps-against-cancer-highlight-challenges-in-early-diagnosis-and-cancer-of-unknown-primary/) - [Event: Tackling challenges in access to medicines for cancer patients](https://www.cancer.eu/event-tackling-challenges-in-access-to-medicines-for-cancer-patients/) - [Event: Cancer, body weight, and healthy diet](https://www.cancer.eu/event-cancer-body-weight-and-healthy-diet/) - [Event: Shortages of inexpensive, essential medicines](https://www.cancer.eu/shortages-of-inexpensive-essential-medicines/) - [Event: Re-innovate cancer treatment](https://www.cancer.eu/event-re-innovate-cancer-treatment/) - [Event: Cancer screening in the EU](https://www.cancer.eu/event-cancer-screening-in-the-eu/) - [Roundtable: Sunbed use, all cost no benefit](https://www.cancer.eu/roundtable-sunbed-use-all-cost-no-benefit/) - [Roundtable: 5th Awareness Week on Alcohol-Related Harm](https://www.cancer.eu/roundtable-5th-awareness-week-on-alcohol-related-harm/) - [Event: Recognising cancer nursing in Europe](https://www.cancer.eu/event-recognising-cancer-nursing-in-europe/) - [Event: Skin cancer registries in Europe](https://www.cancer.eu/event-skin-cancer-registries-in-europe/) - [Event: Celebrating 20 years of progress in paediatric haemato-oncology](https://www.cancer.eu/event-celebrating-20-years-of-progress-in-paediatric-haemato-oncology/) - [World Cancer Day 2017: A statement from the MEPs Against Cancer](https://www.cancer.eu/world-cancer-day-2017-a-statement-from-meps-against-cancer/) - [MEPs Against Cancer: Towards a transformational change for children and adolescents with cancer](https://www.cancer.eu/towards-a-transformational-change-for-children-and-adolescents-with-cancer/) - [MEPs Against Cancer mark 20 years of leadership in the fight against cancer ](https://www.cancer.eu/meps-against-cancer-mark-20-years-of-leadership-in-the-fight-against-cancer/) - [MEPs Against Cancer appoint new leadership](https://www.cancer.eu/meps-against-cancer-appoint-new-leadership/) - [European cancer leagues appoint new President](https://www.cancer.eu/european-cancer-leagues-appoint-new-president/) - [The EU Cardiovascular Health Plan: a golden chance to prevent cardiovascular disease and cancer](https://www.cancer.eu/the-eu-cardiovascular-health-plan-a-golden-chance-to-prevent-cardiovascular-disease-and-cancer/) - [Pharma Package opens doors to more equitable access to medicines, but does not go far enough to lower costs](https://www.cancer.eu/eu-pharma-package-deal-opens-doors-to-more-equitable-access-to-cancer-medicines-but-does-not-go-far-enough-to-lower-costs/) - [Webinar: Breaking down taboos about cancer and sexuality ](https://www.cancer.eu/webinar-breaking-down-taboos-about-cancer-and-sexuality/) - [Managing cancer in the workplace: A handbook for employers and HR professionals ](https://www.cancer.eu/managing-cancer-in-the-workplace-a-handbook-for-employers-and-hr-professionals/) - [New ECL Atlas shows rehabilitation services are an integral part of cancer care](https://www.cancer.eu/new-ecl-atlas-shows-rehabilitation-services-are-an-integral-part-of-cancer-care/) - [International Workers' Day 2024](https://www.cancer.eu/international-workers-day-2024/) - [ECL Rehabilitation Atlas 2016](https://www.cancer.eu/ecl-rehabilitation-atlas-2016/) - [Recommendations for working and collaborating with the pharmaceutical industry](https://www.cancer.eu/recommendations-for-working-and-collaborating-with-the-pharmaceutical-industry/) - [Guide for healthcare professionals: How to support and communicate with informal caregivers](https://www.cancer.eu/guide-for-healthcare-professionals-how-to-support-and-communicate-with-informal-caregivers/) - [The priceless help: best practices on how to manage volunteers in cancer organisations](https://www.cancer.eu/the-priceless-help-best-practices-on-how-to-manage-volunteers-in-cancer-organisations/) - [How to prepare for a medical consultation? Tips and questions to ask your doctor](https://www.cancer.eu/how-to-prepare-for-a-medical-consultation-tips-and-questions-to-ask-your-doctor/) - [Cancer and sex: Leaflet for healthcare professionals](https://www.cancer.eu/cancer-and-sex-leaflet-for-healthcare-professionals/) - [Cancer and sex: Everything you wanted to know about your sexual health](https://www.cancer.eu/cancer-and-sex-everything-you-wanted-to-know-about-your-sexual-health/) - [How to manage cancer at work: Tips for employees diagnosed with cancer](https://www.cancer.eu/how-to-manage-cancer-at-work-tips-for-employees-diagnosed-with-cancer/) - [A better life for cancer patients and survivors: Reflections on comprehensive cancer rehabilitation](https://www.cancer.eu/a-better-life-for-cancer-patients-and-survivors-reflections-on-comprehensive-cancer-rehabilitation/) - [European Parliament's vote on the Wine Package is a significant step towards clear alcohol labelling](https://www.cancer.eu/european-parliaments-vote-on-the-wine-package-is-a-significant-step-towards-clear-alcohol-labelling/) - [Webinar: Chemical pollution and men's health](https://www.cancer.eu/webinar-chemical-pollution-and-mens-health/) - [Critical Medicines Act: Recommendations for the EU Parliament's public health committee](https://www.cancer.eu/critical-medicines-act-recommendations-for-the-eu-parliaments-public-health-committee/) - [Cancer patients across Europe face serious financial and socioeconomic challenges](https://www.cancer.eu/cancer-patients-across-europe-face-serious-financial-and-socioeconomic-challenges-new-study-finds/) - [Tackling challenges in access to medicines for all cancer patients in Europe](https://www.cancer.eu/tackling-challenges-in-access-to-medicines-for-all-cancer-patients-in-europe/) - [Webinar: Launch of the European Fair Pricing Network](https://www.cancer.eu/webinar-launch-of-the-european-fair-pricing-network/) - [Op-ed: Boosting joint procurement to improve access to new medicines in Europe](https://www.cancer.eu/op-ed-boosting-joint-procurement-to-improve-access-to-new-medicines-in-europe/) - [Op-ed: Time for civil society to take action to influence EU regulations on medicines for children and rare diseases](https://www.cancer.eu/op-ed-time-for-civil-society-to-take-action-to-influence-eu-regulations-on-medicines-for-children-and-rare-diseases/) - [Webinar: The revision of EU regulations on medicines for children and rare diseases ](https://www.cancer.eu/webinar-the-revision-of-eu-regulations-on-medicines-for-children-and-rare-diseases/) - [Webinar: Towards fair cancer medicine deals ](https://www.cancer.eu/webinar-towards-fair-cancer-medicine-deals/) - [Health groups welcome European Parliament’s report on the shortage of medicines ](https://www.cancer.eu/health-groups-welcome-european-parliaments-report-on-the-shortage-of-medicines/) - [ECL welcomes Pharmaceutical Strategy's ambitions to make medicines affordable and available for all patients](https://www.cancer.eu/ecl-welcomes-pharmaceutical-strategys-ambitions-to-make-medicines-affordable-and-available-for-all-patients/) - [European Commission’s accepts commitments by Aspen Pharmacare to cut prices for 6 critical cancer drugs](https://www.cancer.eu/european-commissions-accepts-commitments-by-aspen-pharmacare-to-cut-prices-for-6-critical-cancer-drugs/) - [Joint statement on the Hospital Exemption for advanced therapy medicinal products](https://www.cancer.eu/joint-statement-on-the-hospital-exemption-for-advanced-therapy-medicinal-products/) - [Critical Medicines Act paves the way for greater availability of and access to cancer drugs](https://www.cancer.eu/critical-medicines-act-paves-the-way-for-greater-availability-of-and-access-to-cancer-drugs-through-collaborative-procurement/) - [ECL and EORTC welcome CJEU ruling on the EMA's transparency policy](https://www.cancer.eu/ecl-and-eortc-welcome-cjeu-ruling-on-the-emas-transparency-policy/) - [BMJ study highlight the need to improve the life of patients with new innovations](https://www.cancer.eu/bmj-study-highlight-the-need-to-improve-the-life-of-patients-with-new-innovations/) - [ECL recommendations for the Critical Medicines Act](https://www.cancer.eu/ecl-recommendations-for-the-critical-medicines-act/) - [Recommendations for the EU procedures for the authorisation and supervision of medicinal products for human use](https://www.cancer.eu/recommendations-for-the-eu-procedures-for-the-authorisation-and-supervision-of-medicinal-products-for-human-use/) - [WHO/Europe RC72 Ministerial Lunch: “Access tonovel, effective, high-cost medicines”](https://www.cancer.eu/who-europe-rc72-ministerial-lunch-access-tonovel-effective-high-cost-medicines/) - [Bridging efforts to tackle medicine shortages at the EU level](https://www.cancer.eu/bridging-efforts-to-tackle-medicine-shortages-at-the-eu-level/) - [ECL welcomes reflection paper on forecasting demand for medicinal products in the EU](https://www.cancer.eu/ecl-welcomes-reflection-paper-on-forecasting-demand-for-medicinal-products-in-the-eu/) - [Council recommendations on cancer screening: what needs to change?](https://www.cancer.eu/council-recommendations-on-cancer-screening-what-needs-to-change/) - [Enabling informed decision-making about cancer screening participation](https://www.cancer.eu/enabling-informed-decision-making-about-cancer-screening-participation/) - [Webinar: Resuming cancer screening post Covid-19](https://www.cancer.eu/webinar-resuming-cancer-screening-post-covid-19/) - [Lack of awareness is a major barrier to early cancer detection ](https://www.cancer.eu/lack-of-awareness-is-a-major-barrier-to-early-cancer-detection/) - [Promoting and embedding the European Code Against Cancer within screening programmes](https://www.cancer.eu/promoting-and-embedding-the-european-code-against-cancer-within-screening-programmes/) - [Introducing the BUMPER digital health literacy guide](https://www.cancer.eu/empowering-cancer-prevention-bumper-digital-health-literacy-guide/) - [Webinar: Advancing health literacy through the BUMPER project](https://www.cancer.eu/webinar-advancing-health-literacy-through-the-bumper-project/) - [Empowering cancer prevention: BUMPER health literacy guide](https://www.cancer.eu/empowering-cancer-prevention-bumper-health-literacy-guide/) - [Webinar: How will Europe achieve its first tobacco-free generation?](https://www.cancer.eu/webinar-how-will-europe-achieve-its-first-tobacco-free-generation/) - [Webinar: Cracking the future of the European Code Against Cancer](https://www.cancer.eu/webinar-cracking-the-future-of-the-european-code-against-cancer/) - [Webinar: Measuring awareness of the European Code Against Cancer](https://www.cancer.eu/webinar-measuring-awareness-of-the-european-code-against-cancer/) - [Webinar: Alcohol and the European Code Against Cancer](https://www.cancer.eu/webinar-alcohol-and-the-european-code-against-cancer/) - [Policy dialogue: Europe's path to the Tobacco Products Directive 3.0](https://www.cancer.eu/policy-dialogue-europes-path-to-the-tobacco-products-directive-3-0/) - [Webinar: Sun safety and the European Code Against Cancer](https://www.cancer.eu/webinar-sun-safety-and-the-european-code-against-cancer-2/) - [Webinar: Physical activity and the European Code Against Cancer](https://www.cancer.eu/webinar-sun-safety-and-the-european-code-against-cancer/) - [Webinar: Occupational health and the European Code Against Cancer](https://www.cancer.eu/webinar-occupational-health-and-the-european-code-against-cancer/) - [Webinar: Tobacco and the European Code Against Cancer](https://www.cancer.eu/webinar-tobacco-and-the-european-code-against-cancer/) - [Webinar: Environmental health and the European Code Against Cancer](https://www.cancer.eu/webinar-environmental-health-and-the-european-code-against-cancer/) - [EU Food Policy Coalition: Placing healthy, affordable diets at the core of EU Cardiovascular Health Policy.](https://www.cancer.eu/eu-food-policy-coalition-placing-healthy-affordable-diets-at-the-core-of-eu-cardiovascular-health-policy/) - [Letter to Politico: Stop accepting sponsoring by the tobacco industry](https://www.cancer.eu/letter-to-politico-stop-accepting-sponsoring-by-the-tobacco-industry/) - [Over 20 health NGOs call for stronger EU action against alcohol during Breast Cancer Awareness Month](https://www.cancer.eu/over-20-health-ngos-call-for-stronger-eu-action-against-alcohol-during-breast-cancer-awareness-month-2/) - [European Health Alliance on Alcohol: “Safeguarding public health must be central to EU wine policy”  ](https://www.cancer.eu/european-health-alliance-on-alcohol-safeguarding-public-health-must-be-central-to-eu-wine-policy/) - [EU Tobacco Tax proposal paves the way for Europe’s first tobacco-free generation](https://www.cancer.eu/eu-tobacco-tax-proposal-paves-the-way-for-europes-first-tobacco-free-generation/) - [European public health organisations call on EU institutions to lead the transition towards a Tobacco-Free Europe ](https://www.cancer.eu/european-public-health-organisations-call-on-eu-institutions-to-lead-the-transition-towards-a-tobacco-free-europe/) - [United Kingdom, France and Ireland top new European ranking on tobacco control](https://www.cancer.eu/united-kingdom-france-and-ireland-top-new-european-ranking-on-tobacco-control/) - [Six more countries adopt legislation to introduce plain tobacco packaging](https://www.cancer.eu/six-more-countries-adopt-legislation-to-introduce-plain-tobacco-packaging/) - [World Bank publishes report on illicit tobacco trade in support of increased tobacco taxation](https://www.cancer.eu/world-bank-publishes-report-on-illicit-tobacco-trade-in-support-of-increased-tobacco-taxation/) - [110 registered tobacco industry lobbyists in Brussels in 2017](https://www.cancer.eu/110-registered-tobacco-industry-lobbyists-in-brussels-in-2017/) - [More and more countries adopt plain tobacco packaging legislation](https://www.cancer.eu/more-and-more-countries-adopt-plain-tobacco-packaging-legislation/) - [WHO 8th Tobacco Conference concludes with new strategy to accelerate tobacco control efforts ](https://www.cancer.eu/who-8th-tobacco-conference-concludes-with-new-strategy-to-accelerate-tobacco-control-efforts/) - [Tobacco Control Scale 2019: How does your country rate on tobacco control?](https://www.cancer.eu/tobacco-control-scale-2019-how-does-your-country-rate-on-tobacco-control/) - [ECL gives feedback on EU reforms to tobacco tracking legislation](https://www.cancer.eu/ecl-gives-feedback-on-eu-reforms-to-tobacco-tracking-legislation/) - [Tobacco Control Scale 2021](https://www.cancer.eu/tobacco-control-scale-2021/) - [Factsheet: Let's talk about weight and cancer](https://www.cancer.eu/factsheet-lets-talk-about-weight-and-cancer/) ## Pages - [Home](https://www.cancer.eu/) - [Vacancies](https://www.cancer.eu/vacancies/) - [The Board](https://www.cancer.eu/the-board/) - [EU Projects and Joint Actions](https://www.cancer.eu/eu-projects-and-joint-actions/) - [Who we work with](https://www.cancer.eu/who-we-work-with/) - [MEPs Against Cancer](https://www.cancer.eu/meps-against-cancer/) - [European Conference on Tobacco or Health](https://www.cancer.eu/european-conference-on-tobacco-or-health/) - [Members](https://www.cancer.eu/members/) - [Our team](https://www.cancer.eu/team/) - [News & resources](https://www.cancer.eu/news-resources/) - [ECL Manifesto](https://www.cancer.eu/ecl-manifesto/) - [European Week Against Cancer](https://www.cancer.eu/european-week-against-cancer/) - [Patient Support](https://www.cancer.eu/patient-support/) - [Access to Medicines](https://www.cancer.eu/access-to-medicines/) - [Early detection](https://www.cancer.eu/early-detection/) - [Cancer prevention](https://www.cancer.eu/cancer-prevention/) - [Youth Ambassadors](https://www.cancer.eu/youth-ambassadors/) - [Working groups](https://www.cancer.eu/working-groups/) - [European Code Against Cancer](https://www.cancer.eu/european-code-against-cancer/) - [Become a member](https://www.cancer.eu/become-a-member/) - [Transparency](https://www.cancer.eu/transparency/) - [About us](https://www.cancer.eu/about-us/) - [Test page Becausl 1](https://www.cancer.eu/test-page-becausl-1/) - [Flagship initiatives](https://www.cancer.eu/flagship-initiatives/) - [What we do](https://www.cancer.eu/what-we-do/) ## Categories - [Ongecategoriseerd](https://www.cancer.eu/category/geen-categorie/) - [Letters](https://www.cancer.eu/category/letter/) - [Publications](https://www.cancer.eu/category/publication/) - [Webinars](https://www.cancer.eu/category/webinar/) - [News](https://www.cancer.eu/category/news/) ## Tags - [publications - cancer prevention](https://www.cancer.eu/tag/publications-cancer-prevention/) - [publications - vaccination & early detection](https://www.cancer.eu/tag/publications-vaccination-early-detection/) - [publications - access to medicines](https://www.cancer.eu/tag/publications-access-to-medicines/) - [publications - patient support](https://www.cancer.eu/tag/publications-patient-support/) - [publications - eu projects](https://www.cancer.eu/tag/publications-eu-projects/) - [news - cancer prevention](https://www.cancer.eu/tag/news-cancer-prevention/) - [news - vaccination & early detection](https://www.cancer.eu/tag/news-vaccination-early-detection/) - [news - access to medicines](https://www.cancer.eu/tag/news-access-to-medicines/) - [news - patient support](https://www.cancer.eu/tag/news-patient-support/) - [news - eu projects](https://www.cancer.eu/tag/news-eu-projects/) - [letters - cancer prevention](https://www.cancer.eu/tag/letters-cancer-prevention/) - [letters - access to medicines](https://www.cancer.eu/tag/letters-access-to-medicines/) - [webinars - cancer prevention](https://www.cancer.eu/tag/webinars-cancer-prevention/) - [webinars - vaccination & early detection](https://www.cancer.eu/tag/webinars-vaccination-early-detection/) - [webinars - access to medicines](https://www.cancer.eu/tag/webinars-access-to-medicines/) - [webinars - patient support](https://www.cancer.eu/tag/webinars-patient-support/) - [news - MEPs Against Cancer](https://www.cancer.eu/tag/news-meps-against-cancer/) - [events - MEPs Against Cancer](https://www.cancer.eu/tag/events-meps-against-cancer/)